FDA approves Pfizer RSV vaccine for older adults
The approval of a vaccine by Pfizer targeting RSV comes just weeks after the Food and Drug Administration cleared a
Read more
Respiratory syncytial virus
FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns
The FDA is slated to make a decision on whether to approve Pfizer's shot in August before respiratory syncytial virus
Read more
FDA approves GSK’s RSV vaccine for older adults, world’s first shot against virus
The FDA's approval is a victory for GSK in a race against Pfizer and Moderna to bring a shot that
Read more
FDA says Guillain-Barre syndrome is possible risk of Pfizer’s RSV vaccine for older adults
The FDA sees a potential risk and has asked Pfizer to conduct a safety study on Guillain-Barre after a potential
Read more